Literature DB >> 30860995

Strongyloides stercoralis infection: A systematic review of endemic cases in Spain.

Maria Barroso1, Fernando Salvador2, Adrián Sánchez-Montalvá2, Pau Bosch-Nicolau2, Israel Molina2.   

Abstract

BACKGROUND: Strongyloides stercoralis infection, a neglected tropical disease, is widely distributed. Autochthonous cases have been described in Spain, probably infected long time ago. In recent years the number of diagnosed cases has increased due to the growing number of immigrants, travelers and refugees, but endemically acquired cases in Spain remains undetermined.
METHODOLOGY: We systematically searched the literature for references on endemic strongyloidiasis cases in Spain. The articles were required to describe Strongyloides stercoralis infection in at least one Spanish-born person without a history of travel to endemic areas and be published before 31st May 2018. Epidemiological data from patients was collected and described individually as well as risk factors to acquisition of the infection, diagnostic technique that lead to the diagnosis, presence of eosinophilia and clinical symptoms at diagnosis.
FINDINGS: Thirty-six studies were included, describing a total of 1083 patients with an average age of 68.3 years diagnosed with endemic strongyloidiasis in Spain. The vast majority of the cases were described in the province of Valencia (n = 1049). Two hundred and eight of the 251 (82.9%) patients in whom gender was reported were male, and most of them had current or past dedication to agriculture. Seventy percent had some kind of comorbidity. A decreasing trend in the diagnosed cases per year is observed from the end of last decade. However, there are still nefigw diagnoses of autochthonous cases of strongyloidiasis in Spain every year.
CONCLUSIONS: With the data provided by this review it is likely that in Spain strongyloidiasis might have been underestimated. It is highly probable that the infection remains undiagnosed in many cases due to low clinical suspicion among Spanish population without recent travel history in which the contagion probably took place decades ago.

Entities:  

Mesh:

Year:  2019        PMID: 30860995      PMCID: PMC6413904          DOI: 10.1371/journal.pntd.0007230

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


Introduction

Strongyloidiasis is a disease caused by soil-transmitted helminths, mainly by the species Strongyloides stercoralis. This intestinal nematode infects an estimated 300 million people worldwide, although this is probably underestimated. It is one of the most neglected of the neglected tropical diseases (NTD) and is widely distributed [1-2]. Although it generally occurs in subtropical and tropical countries, transmission is also possible in countries with temperate climates. Autochthonous cases have been described in Spain, possibly infected long time ago. It remains uncertain whether S. stercoralis is currently endemic in Spain. Still, some authors consider this country and some other southern European countries as endemic [3]. The life cycle of S. stercoralis is complex and follows multiple routes, including a complete life cycle outside the human host. The most frequent mechanism of infection is percutaneous entry of the filariform larvae. In healthy people, most of the cases are asymptomatic, although it can cause intermittent symptoms that mainly affect the intestine, the lungs or the skin [4]. About criterion used to establish the diagnosis of strongyloidiasis is not homogenized among the centers. The diagnostic laboratory criterion of strongyloidiasis is the observation of larval stages. However, in chronic infection, larvae excretion may be low and fluctuating, and microscopic observation is not sensitive enough and multiple stool specimens should be analyzed to increase the sensitivity of the method. The clinical criterion is a patient with epidemiological antecedents and any of the associated clinical manifestations, especially if it is an immunosuppressed patient. These methods are laborious, time consuming, and in the case of fecal culture, requires well trained technicians in order to differentiate S. stercoralis. Several immunological tests have also been described (ELISA, IFAT and Western blot) with variable sensitivity and specificity depending on the population tested among other factors [1]. Alternative diagnostic methods, such as molecular biology techniques (mostly polymerase chain reaction, PCR) have been implemented. However, PCR might not be suitable for screening purpose, whereas it might have a role as a confirmatory test, since it still misses a relevant proportion of infected people [5]. Due to the subtle symptoms, low sensitivity of diagnostic techniques and the complex lifecycle that can cause asymptomatic autoinfection for decades, the prevalence of S. stercoralis is thought to be severely underestimated. Typically risk factors for severe infection include immunosuppression, certain malignancies, human T-cell lymphotropic virus type 1 infection, and alcoholism. Likewise, S. stercoralis has been associated with agricultural or mining activities. In Germany, it was recognized as a parasitic professional disease in miners [6]. S. stercoralis infection has also been linked to low socioeconomic factors and infrastructure, indicating that it as a disease of disadvantage [7-8]. In recent years the number of diagnosed cases has been increasing in high income countries due to the growing number of immigrants, travelers and refugees [9-10]. To provide information on this topic, a systematic review of the cases of endemic strongyloidiasis in Spain was carried out, as well as the description of the epidemiological characteristics of these patients.

Methods

Aiming to assemble all scientific articles based on endemic strongyloidiasis diagnosed in Spain, a systematic review was carried out. Relevant articles were retrieved from PubMed, EMBASE, Scielo, ISI Web of Knowledge, and Cochrane Library databases using combinations of the search terms adapted to each database. Additionally, Gray Literature in the form of communications presented at national congresses was performed, as well as OpenGrey. As a secondary source, Google Scholar and free internet search was used for non-indexed articles. The keywords were “Strongyloides stercoralis”, “soil-transmitted helminthiasis”, “endemic”, and “Spain”. The following combinations of MeSH were used in PubMed: (Strongy* [MeSH] AND Spain), ("Strongyloidiasis" [MeSH] AND Spain NOT "imported" NOT "immigrant"), and ("Strongyloidiasis" [MeSH] AND "endemic" AND "Spain"). The selection criteria were articles published in any language until May 31st 2018 that contained the description of at least one human case of infection with S. stercoralis acquired in Spain without a history of travel to endemic areas. No restrictions were applied based on the study design or data collection. Human filter was applied. A manual search of the bibliographical references cited in the relevant articles was carried out. All potential articles were analyzed by two researchers to assess compliance with the selection criteria. In situations of missed information, the corresponding author of the paper was contacted to gather the information. If the author answered the required information to fulfill the inclusion criteria, those articles were considered. If not, they were excluded because they could not ensure the endemic acquisition. The exclusion criteria included: animal studies, cases in which endemic infection could not be assured, cases of foreigners from an endemic country for S. stercoralis, native people with trips to endemic or probably endemic countries in the past (e.g. Italy, France or Portugal), transplanted people in which this contagion route could not be excluded, and duplicated cases. Based on these criteria the articles were reviewed in two stages. In the first stage, articles were selected by titles and abstracts according to selection criteria. In the second stage, the full text of the articles was analyzed. Finally, the articles that met the selection criteria were included in the study. From each study the following data was extracted: the study period, year of publication and number of endemic cases described. The following epidemiological data from patients described in the studies was collected: age, gender, geographical origin, medical comorbidities and concomitant treatments, occupation (or hobbies if relevant), other risk factors, year of diagnosis, diagnostic technique used for diagnosis, presence of eosinophilia and clinical symptoms.

Results

Thirty-six studies were included describing a total of 1083 patients with endemic strongyloidiasis in Spain (see Tables 1 and 2) [11-46]. The average age of the described cases was 68.35 years, ranging from 17 to 100 years old. Two hundred and eight of the 251 (82.9%) patients in whom gender was reported were male, and most of them had current or past dedication to agriculture. The province in whom most cases were described was Valencia, with 1049 people diagnosed. Alicante had 13 and Murcia 5, eventually describing cases in provinces of coastal oceanic climate with abundant rainfall most of the year and temperatures below 22°C (Cantabria, Asturias, and Pontevedra). See Fig 1.
Table 1

Main characteristics of included articles.

ReferenceStudy periodNumber of casesYear of publication
Duvignaud et al [11]12016
Valerio et al [12]01/2003–12/201222013
Fernández Rodríguez et al [13]12012
Mayayo et al [14]12005
Oltra Alcaraz et al [15]2612004
Martinez-Vazquez et al [16]12003
Román Sanchez et al [17]312003
Román Sanchez et al [18]1522001
Rodríguez Calabuig* et al [19]10/1997–10/1999152001
Cremades Romero et al [20]11996
Rodríguez Calabuig* et al [21]01/1994–06/1997151998
Llagunes et al [22]12010
Esteve-Martínez et al [23]12013
Olmos et al [24]199712004
López Gaona et al [25]12009
Escudero-Sanchez et al [26]12017
Pacheco-Tenza et al [27]01/1999–03/201642016
Esteban Ronda et al [28]12016
Martinez-Perez et al [29]2000–201512018
Igual Adell et al [30]2007
Pretel Serrano et al [31]1994–199932001
Ortiz Romero et al [32]12007
Batista et al [33]11992
Llenas García et al [34]01/1999–12/201792018
Tornero et al [35]01/2002–12/20174232018
Corbacho Loarte et al [36]01/2008–12/201512017
García García et al [37]2009–201022011
Igual et al [38]2004–20051122006
Lozano Polo et al [39]12005
Cremades Romero et al [40]04/1994–10/1995321997
Sanchis-Bayarri et al [41]11981
Tirado et a [42]12002
Nevado et al [43]11996
Sampedro et al [44]11988
Lopez Gallardo et al [45]11997
Toldos et al [46]11995

* Data obtained through clarification of the main author

Table 2

Clinical and epidemiological characteristics of patients with autochtonous strongyloidiasis in Spain.

Gender and age (in years)City and province of residenceOccupationComorbidity or concomitant treatmentOther risk factorsYear of diagnosisDiagnostic techniquesPresence of eosinophilia.Eosinophils count per mm3.Percentage of eosinophils in white blood cell /percentage of patients with eosinophilia if relevantClinical symptomsRef.
W 17La Safor, ValenciaNo dataNo dataWalking barefoot2005Fresh stool examination and/or fecal cultureYes,16,900Abdominal pain, diarrhea and weight loss[11]
W 61No dataNo dataAsthma and chronic eosinophilic pneumonia.No data2011SerologyYes1,48020%Chronic urticaria and abdominal pain[13]
M 79Zaragoza, AragónNo dataMild malnutritionNo data2004Bronchial aspirate examinationNoAbdominal pain[14]
261 M+W patients, 21–100 years oldLa Safor, Valencia124 agriculture activities, 18 construction activitiesNo data33 irrigation ditches cleaners, 6 ditch baths1995–1999Fresh stool examination, Baermann test and fecal cultureNo dataNo data[15]
M 25Fornelos de Montes, PontevedraLogging companyNo dataOccasional agricultural work and bathing in river2002Fresh stool examination, and examination after concentration (Ritchie)Yes22,000Nonspecific skin lesions and abdominal pain[16]
31 M patients, mean age 68.6 ± 8.0Gandía, ValenciaFarmersNo dataWork barefoot2003Fresh stool examination and/or fecal cultureNo dataNo data[17]
120 M and 32 W, mean age 67Gandía, ValenciaFarmers and farmer´s wives44 COPD(no further details), 38 heart disease, 7 solid neoplasia, and1 HIV infection (no further details99 work barefoot or were spouses of farmers, 13 drink non-potable water1990–1997Fresh stool examination and fecal culture82% (n = 125) had eosinophiliamedian count:1,357+-811severe cases median count694 +-30941.65% (n = 63) were asymptomatic,13% (n = 20) had hyperinfection syndrome or disseminated strongyloidiasis[18]
15 patients, mean age 66 ± 10Oliva, Valencia68% farmers (rice and citric)No dataNo data1997–1999Fresh stool examination and fecal culture100% (n = 15) patients had eosinophilia (>500 eosinophils)49% cough, 47% pruritus, and 38% dyspepsia[19]
M 70Ribera Baixa, ValenciaFarmerCOPD (FEV1 48%) + corticosteroidsNo data1995Fresh stool examination and/or fecal cultureYes12,60034%Nausea, vomits, weight loss and abdominal pain[20]
15 M+W, mean age 65 (SD 11.5)Oliva, ValenciaFarmersNo data66.6% had some risk factor (work barefoot, drink non-potable water)1994–1997Fresh stool examination and/or fecal cultureNo data56.6% symptoms (12% cough)[21]
M 76Valencia ProvinceNo dataCrohn´s disease + corticosteroidsNo data2009Bronchoalveolar lavageNoFever, arthralgia, dyspnea[22-23]
M 57Santander, CantabriaNo dataHIV infectionCD4 42/mm3Rheumatoid arthritisCorticosteroids+ ImmunosuppressionNo data2003Postmortem histopathological examination (trachea, lungs, ileum, cecum and pericolonic lymph nodes)NoAnorexia, dysphagia, odynophagia, night sweats, weight loss, diarrhea, and acute respiratory distress[24]
W 82Restiello-Grado,AsturiasNo dataNo dataGardening hobby2008Fresh stool examination and/or fecal cultureYes6,12038%Abdominal pain and diarrhea[25]
M 85Born in Extremadura, living in MadridFarmerNo dataNo data2017SerologyNo dataNo data[26]
M 69Orihuela, AlicanteFarmerLung carcinoma, chemotherapy, inhaled corticosteroidsNo data2007Sputum examinationYes600Hemoptysis, hyperinfection syndrome[27]
W 73Redovan / Vega Baja del Segura. AlicanteFarmerDiverticular diseaseNo data2015SerologyYes2,700Abdominal pain and diarrhea[27]
M 80Orihuela, AlicanteFarmerBladder tumorNo data2015Fresh stool examination and/or fecal cultureYes700Abdominal pain, pruritus[27]
M 72Orihuela, AlicanteCarrierCOPD (no further details)+ corticosteroidsFarmer's work in his free time2015Fecal culture, serology, histopathological examination (colon)biopsy)Yes2,400Hyperinfection syndrome[27]
M 84Chella, Valencia*FarmerGastrectomy, asplenia, malnutrition and treatment with corticosteroidsWalk barefoot2016Bronchial aspirate examinationNoAsthenia, dysphagia, low-grade fever, anorexia, and weight loss[28]
M 40Sta Cruz de Tenerife, CanariasConstruction workerImmunosuppressionWalk barefoot in mud2006Fresh stool examinationYesNo further dataHyperinfection syndrome[29]
M 81Vega del Segura, MurciaFarmerCOPD (FEV1 42%)Walk barefoot1998Fresh stool examinationYes150021%Abdominal pain and pruritus[31]
M 77Vega del Segura, MurciaFarmerCOPD(FEV1 30%)+ corticosteroidsWalk barefoot1999Fresh stool examinationYes1,10011%Bronchospasm, hemoptysis[31]
M 82Vega del Segura. MurciaFarmerCOPD (no further details) + corticosteroidsWalk barefoot1999Fresh stool examinationYes3,90029%Dyspnea, wheezing, abdominal pain, meteorism, and pruritus[31]
M 85MurciaNo dataCOPD (FEV1 50%)Corticosteroids for the last monthNo data2008Bronchial aspirate examinationYes3,10040.8%Cough and dyspnea[32]
M 35Sta Cruz de Tenerife, CanariasNo dataHIV infectionCD4 36No data1992Fresh stool examination and/or fecal cultureNoCough, fever, vomits, and diarrhea[33]
8 M and 1 W, mean age 79Orihuela, Alicante6 farmers2 neoplasia, 3 COPD (no further details) + corticosteroidsNo data1999–2017Fresh stool examination and/or fecal culture, and serology88.9% (n = 8) patients had eosinophiliamedian count 700[34]
54 patients, mean age 72.6 (SD 9)La Safor. Valencia60% former rice farmersNo dataIn 4 of them bathing in marshy waters for recreational reasons was assumed, or parents had worked on rice fields2009:17 cases2010: 12 cases2011: 10 cases2012: 5 cases2013: 1 case2014: 4 cases2015:2 cases2016: 1 case2017: 2 casesFresh stool examination and/or fecal cultureNo dataNo data[35]
No dataNo dataNo dataNo dataNo data2008–2015Harada Mori, Baerman and/or fecal cultureNo dataNo data[36]
2 patientsValencia. ValenciaNo dataNo dataNo data2009–2010Fecal culture and Ritchie concentration methodNo dataNo data[37]
112 patientsGandía. ValenciaNo dataNo dataNo data2004–2005Fresh stool examination and/or fecal cultureNo dataNo data[38]
W 64Santander, CantabriaNo dataAsthma + corticosteroidsNo data2005Fresh stool examination and/or fecal cultureYes70014%Bilateral pleural effusion and respiratory failure[39]
28 M + 4 W, mean age 68 (SD 7)La Safor, ValenciaFarmers62% of patients with comorbidities: COPD, asthma, alcoholism, diabetes mellitus, and neoplasiaWalk barefoot1994–1995Fresh stool examination and/or fecal culture, and bronchoalveolar lavage100% (n = 32) had eosinophilia (>600)65% had respiratory, digestive and/or cutaneous symptoms[40]
M 71Oliva. ValenciaFarmerNo dataWalk barefoot1981Cytological examination of an abdominal puncture, fresh stool examination and/or fecal cultureYes6,840(38%)Vomits and abdominal pain[41]
M 71Vinaroz, CastellónFarmerCOPD (no further details) + corticosteroidsWalk barefoot2002Bronchial aspirate examinationNoAcute respiratory and renal failure, rash, and hemoptysis[42]
W 63CantabriaNo dataAsthma + corticosteroidsNo data1996Fresh stool examinationYes19%Dyspnea, cough, expectoration, diarrhea, vomits and pruritus[43]
M 77Oviedo, AsturiasCoal MinerCOPD (FEV1 30–50%) + inhaled corticosteroids and alcoholNo data1988Histopathological examination (duodenal biopsy)NoWeight loss and gastrointestinal symptoms[44]
M 71Almería, AlmeríaNo dataUlcerative colitis + corticoidsNo data1997Bronchial aspirate,stool and sputum examination, histopathological examination (colon biopsy)NoAbdominal pain, diarrhea, fever, dyspnea, cough, and expectoration[45]
M 58Vega Media del Segura, MurciaFarmerCOPD (no further details) + corticosteroidsNo data1994Histopathological examination (duodenal biopsy), fecal cultureYes12,49644%Abdominal pain, diarrhea, vomits, and weight loss[46]

* Data obtained through clarification of the main author.

Fig 1

Geographical distribution of autochthonous Strongyloides stercoralis infection in Spain.

The map was obtained from the open access website http://mapsvg.com/maps.

Geographical distribution of autochthonous Strongyloides stercoralis infection in Spain.

The map was obtained from the open access website http://mapsvg.com/maps. * Data obtained through clarification of the main author * Data obtained through clarification of the main author. Regarding the number of diagnosed cases per year, a decreasing trend is observed since the beginning of this decade. The year with higher number of diagnosed cases was 2003, with 82 patients. Since 2011, no more than 10 cases have been reported annually (Fig 2).
Fig 2

Number of patients diagnosed with autochthonous Strongyloides stercoralis infection in Spain per year.

Only patients from articles that clearly specified the year of diagnosis of each case were included.

Number of patients diagnosed with autochthonous Strongyloides stercoralis infection in Spain per year.

Only patients from articles that clearly specified the year of diagnosis of each case were included. The technique that led to the diagnosis of strongyloidiasis was described in 743 patients from twenty-six different articles. In some cases, different techniques were used for the same diagnosis. In 692 patients (93.1%), the technique used for the definitive diagnosis of strongyloidiasis was the fresh stool examination, specific fecal culture, the Baermann test, the Ritchie technique or the Harada Mori technique. In 39 patients (5.2%) the diagnosis was made by the sputum or bronchoalveolar lavage examination. In 6 cases (0.8%) the diagnosis was made by serological techniques and in another 6 cases (0.8%) the diagnosis was made by histopathological analysis. In 26 of the 37 patients individually described, comorbidities were reported. Out of those, most frequent were diseases that associate the use of corticosteroids such as: chronic obstructive pulmonary disease (COPD), asthma, and inflammatory bowel diseases or immunosuppressive conditions due to advanced HIV infection (AIDS stage) or malignancies. In all patients diagnosed with COPD, severity of airflow limitation (FEV1) was according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria at least moderate GOLD 2 (50% ≤ FEV1 < 80% predicted) if not severe: GOLD 3 (30% ≤ FEV1 < 50% predicted). Overall, 70.3% of these patients had at least one comorbidity. In patients in whom blood test results were reported, 41 out of the 50 (82%) exhibited eosinophilia. The median eosinophil count in patients with eosinophilia was 4,057 eosinophil/mm3; considering 24 individual reported counts.

Discussion

Strongyloidiasis prevalence may be underestimated in many countries. With the data provided by this review it is likely that underestimation could have been a reality for the last five decades in Spain. The main cause would be the lack of clinical suspicion. But also the subtle symptoms, the decades-long persistence of infection in untreated hosts and the absence of a diagnostic test of choice with high sensitivity and specificity would ultimately contribute. An important finding of our work is that almost 97% of all published infections occurred in the province of Valencia. The fact that most cases diagnosed and published are in the province of Valencia, can respond to various reasons. Firstly, the area had the perfect combination of temperature and humidity, population exposed to S. stercoralis for occupational reasons such as rice farmers or irrigation ditch cleaners (activities that were characteristically carried out barefoot) and hygiene factors of rural areas during the 1960s (lack of drinking water and toilets in some homes). It is noteworthy that no cases of strongyloidiasis have been reported in other areas with similar climatology and population equally dedicated to the cultivation of rice fields, such as the Delta del Ebro in Tarragona province. We consider highly probable that there has been transmission in other areas outside those described. Secondly, health care professionals in the area of Valencia probably had a greater awareness of the infection, with a higher suspicion and therefore a higher number of diagnoses. Although we concur that the estimated prevalence of S. stercoralis by one highly cited article is not representative of the entire country, we disagree that Spain should not be considered an endemic country [17]. However, autochthonous cases have been anecdotal in the last decade, as indicated by Martinez-Perez [47]. The results of the individuals diagnosed showed an average age close to 70 years old. Given the known characteristics of the disease the contagion probably took place decades before the diagnosis, coinciding with the postwar period where hygienic conditions and infrastructure were affected. On one hand, factors of unavoidable mention that directly affect the transmission of this helminth are the improvement in hygienic conditions and the mechanization of agricultural work. On the other hand, the increase of awareness by health care workers, especially from the most affected communities, may have led to the diagnosis of new cases in recent years. An overall higher incidence rate in male gender is described, which is consistent with previous studies [15, 17, 21, 27]. This might be explained due to a gender biased; since some articles focus on screening high risk population (farmers or smokers with COPD), traditionally associated with gender roles. Regarding the diagnostic techniques used, there is great heterogeneity among the different studies. The sensitivity of techniques based on microscopy is not good enough, particularly in chronic infections. Serology is a useful tool but could overestimate the prevalence of the disease due to cross-reactivity with other nematode infections and its difficulty distinguishing recent and past (and cured) infections. However, current serological tests are specific enough and negativization or a decrease in the titers could be observed 6–12 month after treatment, making this tool very useful [48]. There are some limitations that have to be mentioned. Inevitably there are cases of strongyloidiasis that have not been written for publication. In addition, ten articles had to be excluded due to lack of information about travel history or did not comply with the minimum information required. Therefore, it is highly probable that there were more than 1083 cases. Lastly, given the characteristics of this review, it is possible that there are some duplicate cases in multiple description articles and described individually by another researcher. In summary, there are still new diagnoses of autochthonous cases of strongyloidiasis in Spain every year, especially as occupational hazard in a specific Spanish region. Although the number of diagnoses is much lower than in the past decade, it is highly probable that the infection remains undiagnosed due to low clinical suspicion among Spanish population without recent travel history. Epidemiological studies in at risk areas based on serological techniques could give more information about the real situation of autochthonous cases of strongyloidiasis in Spain.

Checklist.

(DOC) Click here for additional data file.

Flow diagram.

(DOC) Click here for additional data file.
  39 in total

1.  [Strongyloides stercoralis infestation in patients with chronic obstructive lung disease in Vega del Segura (Murcia). 3 case reports].

Authors:  L Pretel Serrano; M A Page del Pozo; M R Ramos Guevara; J M Ramos Rincón; M C Martínez Toldos; F Herrero Huerta
Journal:  Rev Clin Esp       Date:  2001-02       Impact factor: 1.556

2.  [Respiratory and renal insufficiency in a COPD patient receiving corticoid treatment].

Authors:  María Dolores Tirado; María Gil; José Galiano; Francisco Pardo; Rosario Moreno; Alfonso G Del Busto; Susana Sabater; Bárbara Gomila
Journal:  Enferm Infecc Microbiol Clin       Date:  2002-10       Impact factor: 1.731

3.  [Strongyloidiasis in a patient with acquired immunodeficiency syndrome].

Authors:  N Batista; M F Dávila; H Gijón; M A Pérez
Journal:  Enferm Infecc Microbiol Clin       Date:  1992 Aug-Sep       Impact factor: 1.731

4.  Characteristics and geographical profile of strongyloidiasis in healthcare area 11 of the Valencian community (Spain).

Authors:  Carles Oltra Alcaraz; Rafael Igual Adell; Pilar Sánchez Sánchez; Maria José Viñals Blasco; Oscar Andreu Sánchez; Antonio Sarrión Auñón; David Rodríguez Calabuig
Journal:  J Infect       Date:  2004-08       Impact factor: 6.072

5.  Endemic strongyloidiasis on the Spanish Mediterranean coast.

Authors:  P R Sánchez; A P Guzman; S M Guillen; R I Adell; A M Estruch; I N Gonzalo; C R Olmos
Journal:  QJM       Date:  2001-07

6.  Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytology.

Authors:  E Mayayo; V Gomez-Aracil; J Azua-Blanco; J Azua-Romeo; J Capilla; R Mayayo
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

7.  Disseminated strongyloidiasis in a patient with acquired immunodeficiency syndrome.

Authors:  José M Olmos; Soledad Gracia; Fernando Villoria; Ricardo Salesa; Jesús González-Macías
Journal:  Eur J Intern Med       Date:  2004-12       Impact factor: 4.487

8.  [Agricultural occupation and strongyloidiasis. A case-control study].

Authors:  D Rodríguez Calabuig; R Igual Adell; C Oltra Alcaraz; P Sánchez Sánchez; M Bustamante Balen; F Parra Godoy; E Nagore Enguidanos
Journal:  Rev Clin Esp       Date:  2001-02       Impact factor: 1.556

9.  [Strongyloides stercoralis in the south of Galicia].

Authors:  C Martínez-Vázquez; G González Mediero; M Núñez; S Pérez; J M García-Fernaández; B Gimena
Journal:  An Med Interna       Date:  2003-09

10.  High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries.

Authors:  P Román-Sánchez; A Pastor-Guzmán; S Moreno-Guillén; R Igual-Adell; S Suñer-Generoso; C Tornero-Estébanez
Journal:  Am J Trop Med Hyg       Date:  2003-09       Impact factor: 2.345

View more
  11 in total

1.  Is there autochthonous strongyloidiasis in Spanish children?

Authors:  Jorge Bustamante; Sara Pérez-Muñoz; Talía Sainz; Milagros García Lopez-Hortelano; Dolores Montero-Vega; María José Mellado
Journal:  Eur J Pediatr       Date:  2021-01-11       Impact factor: 3.183

2.  Association of Strongyloides stercoralis infection and type 2 diabetes mellitus in northeastern Thailand: Impact on diabetic complication-related renal biochemical parameters.

Authors:  Manachai Yingklang; Apisit Chaidee; Rungtiwa Dangtakot; Chanakan Jantawong; Ornuma Haonon; Chutima Sitthirach; Nguyen Thi Hai; Ubon Cha'on; Sirirat Anutrakulchai; Supot Kamsa-Ard; Somchai Pinlaor
Journal:  PLoS One       Date:  2022-05-31       Impact factor: 3.752

3.  From the feces to the genome: a guideline for the isolation and preservation of Strongyloides stercoralis in the field for genetic and genomic analysis of individual worms.

Authors:  Siyu Zhou; Dorothee Harbecke; Adrian Streit
Journal:  Parasit Vectors       Date:  2019-10-22       Impact factor: 3.876

4.  Eosinophilia and abdominal pain after severe pneumonia due to COVID 19.

Authors:  Ilduara Pintos-Pascual; Marcos López-Dosil; Ciara Castillo-Núñez; Elena Múñez-Rubio
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2020-11-10

5.  Strongyloidiasis in Southern Alicante (Spain): Comparative Retrospective Study of Autochthonous and Imported Cases.

Authors:  Ana Lucas Dato; María Isabel Pacheco-Tenza; Emilio Borrajo Brunete; Belén Martínez López; María García López; Inmaculada González Cuello; Joan Gregori Colomé; María Navarro Cots; José María Saugar; Elisa García-Vazquez; José Antonio Ruiz-Maciá; Jara Llenas-García
Journal:  Pathogens       Date:  2020-07-23

6.  Performance evaluation of Baermann techniques: The quest for developing a microscopy reference standard for the diagnosis of Strongyloides stercoralis.

Authors:  Woyneshet Gelaye; Nana Aba Williams; Stella Kepha; Augusto Messa Junior; Pedro Emanuel Fleitas; Helena Marti-Soler; Destaw Damtie; Sissay Menkir; Alejandro J Krolewiecki; Lisette van Lieshout; Wendemagegn Enbiale
Journal:  PLoS Negl Trop Dis       Date:  2021-02-18

7.  Global prevalence and epidemiology of Strongyloides stercoralis in dogs: a systematic review and meta-analysis.

Authors:  Aida Vafae Eslahi; Sima Hashemipour; Meysam Olfatifar; Elham Houshmand; Elham Hajialilo; Razzagh Mahmoudi; Milad Badri; Jennifer K Ketzis
Journal:  Parasit Vectors       Date:  2022-01-10       Impact factor: 3.876

8.  Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis.

Authors:  Natalia Tiberti; Dora Buonfrate; Carmine Carbone; Geny Piro; Zeno Bisoffi; Chiara Piubelli
Journal:  Parasit Vectors       Date:  2020-10-15       Impact factor: 3.876

9.  Seropositivity and geographical distribution of Strongyloides stercoralis in Australia: A study of pathology laboratory data from 2012-2016.

Authors:  Jennifer Shield; Sabine Braat; Matthew Watts; Gemma Robertson; Miles Beaman; James McLeod; Robert W Baird; Julie Hart; Jennifer Robson; Rogan Lee; Stuart McKessar; Suellen Nicholson; Johanna Mayer-Coverdale; Beverley-Ann Biggs
Journal:  PLoS Negl Trop Dis       Date:  2021-03-09

10.  Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol.

Authors:  Fernando Salvador; Ana Lucas-Dato; Silvia Roure; Marta Arsuaga; Asunción Pérez-Jacoiste; Magdalena García-Rodríguez; José A Pérez-Molina; Dora Buonfrate; José María Saugar; Israel Molina
Journal:  Pathogens       Date:  2021-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.